Heart Health Institute

Scarborough Village, Ontario M1B 4Z8

0 studies enrolling now · 5 studies all time

What they study most

Atrial Fibrillation, Coronary Stenosis, Heart Failure, Myocardial Infarction, Prevention of Stroke or Systemic Embolism

Studies at this site

• EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction) — Completed
• A Study to Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for Stroke — Stopped early
• Investigation of the Ringer Perfusion Balloon Catheter (Ringer PTCA) — Completed
• EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved) — Completed
• EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced) — Completed